{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:02:12Z","timestamp":1789725732820,"version":"4.0.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Development and Promotion of Science and Technology Talents Project"},{"DOI":"10.13039\/501100005621","name":"Kasetsart University Research and Development Institute","doi-asserted-by":"publisher","award":["FF(KU-SRIU)13.67"],"award-info":[{"award-number":["FF(KU-SRIU)13.67"]}],"id":[{"id":"10.13039\/501100005621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00941-z","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:19:49Z","timestamp":1789715989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of potential SARS-CoV-2 Mpro inhibitors from a Thai natural product database via interaction fingerprint-based virtual screening"],"prefix":"10.1007","volume":"40","author":[{"given":"Aunlika","family":"Chimprasit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supa","family":"Hannongbua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7980-1473","authenticated-orcid":false,"given":"Patchreenart","family":"Saparpakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Rognan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"941_CR1","doi-asserted-by":"publisher","first-page":"1009393","DOI":"10.3389\/fpubh.2022.1009393","volume":"10","author":"S Naseer","year":"2023","unstructured":"Naseer S, Khalid S, Parveen S, Abbass K, Song H, Achim MV (2023) COVID-19 outbreak: impact on global economy. Front Public Health 10:1009393","journal-title":"Front Public Health"},{"key":"941_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00815-1","volume":"9","author":"C Fischer","year":"2024","unstructured":"Fischer C, Willscher E, Paschold L, Gottschick C, Klee B, Diexer S, Bosurgi L, Dutzmann J, Sedding D, Frese T, Girndt M, Hoell JI, Gekle M, Addo MM, Wiesch JSZ, Mikolajczyk R, Binder M, Schulthei\u00df C (2024) SARS-CoV-2 vaccination may mitigate dysregulation of IL-1\/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition. NPJ Vaccines 9:23","journal-title":"NPJ Vaccines"},{"key":"941_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101703","volume":"54","author":"JH McMahon","year":"2022","unstructured":"McMahon JH, Lau JS, Coldham A, Roney J, Hagenauer M, Price S, Bryant M, Garlick J, Paterson A, Lee SJ, O\u2019Bryan J, Hearps A, Tachedjian G, Pinskier H, Phillips C, Garrow S, Pinskier N, Melvin R, Blakeway L, Peleg AY (2022) Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial. EClinicalMedicine 54:101703","journal-title":"EClinicalMedicine"},{"key":"941_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s15010-022-01821-y","volume":"50","author":"S R\u00fcfenacht","year":"2022","unstructured":"R\u00fcfenacht S, Gantenbein P, Boggian K, Flury D, Kern L, Dollenmaier G, Kohler P, Albrich WC (2022) Remdesivir in coronavirus disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series. Infection 50:783\u2013790","journal-title":"Infection"},{"key":"941_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.855496","volume":"13","author":"L Tian","year":"2022","unstructured":"Tian L, Pang Z, Li M, Lou F, An X, Zhu S, Song L, Tong Y, Fan H, Fan J (2022) Molnupiravir and its antiviral activity against COVID-19. Front Immunol 13:855496","journal-title":"Front Immunol"},{"key":"941_CR6","doi-asserted-by":"publisher","first-page":"e935952-1","DOI":"10.12659\/MSM.935952","volume":"28","author":"DV Parums","year":"2022","unstructured":"Parums DV (2022) Editorial: current status of oral antiviral drug treatments for SARS-CoV-2 infection in non-hospitalized patients. Med Sci Monit 28:e935952-1-e935952-4","journal-title":"Med Sci Monit"},{"key":"941_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.37201\/req\/002.2022","volume":"35","author":"J Reina","year":"2022","unstructured":"Reina J, Iglesias C (2022) Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination. Rev Esp Quimioter 35:236\u2013240","journal-title":"Rev Esp Quimioter"},{"key":"941_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13952","volume":"9","author":"VE Hillary","year":"2023","unstructured":"Hillary VE, Ceasar SA (2023) An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines. Heliyon 9:e13952","journal-title":"Heliyon"},{"issue":"6","key":"941_CR9","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1080\/07391102.2020.1839563","volume":"40","author":"S Ahamad","year":"2022","unstructured":"Ahamad S, Gupta D, Kumar V (2022) Targeting SARS-CoV-2 nucleocapsid oligomerization: insights from molecular docking and molecular dynamics simulations. J Biomol Struct Dyn 40(6):2430\u20132443","journal-title":"J Biomol Struct Dyn"},{"key":"941_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.866474","volume":"13","author":"S Ahamad","year":"2022","unstructured":"Ahamad S, Ali H, Secco I, Giacca M, Gupta D (2022) Anti-fungal drug anidulafungin inhibits SARS-CoV-2 spike-induced syncytia formation by targeting ACE2-Spike protein interaction. Front Genet 13:866474","journal-title":"Front Genet"},{"issue":"5","key":"941_CR11","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1021\/acschemneuro.1c00019","volume":"12","author":"K Prasad","year":"2021","unstructured":"Prasad K, Ahamad S, Kanipakam H, Gupta D, Kumar V (2021) Simultaneous inhibition of SARS-CoV-2 entry pathways by cyclosporine. ACS Chem Neurosci 12(5):930\u2013944","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"941_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/07391102.2020.1811774","volume":"40","author":"S Ahamad","year":"2022","unstructured":"Ahamad S, Kanipakam H, Gupta D (2022) Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. J Biomol Struct Dyn 40(1):263\u2013275","journal-title":"J Biomol Struct Dyn"},{"key":"941_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173664","volume":"890","author":"S Ahamad","year":"2021","unstructured":"Ahamad S, Kanipakam H, Birla S, Ali MS, Gupta D (2021) Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 Mpro, using molecular docking and dynamics simulation studies. Eur J Pharmacol 890:173664","journal-title":"Eur J Pharmacol"},{"key":"941_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127377","volume":"30","author":"S Ullrich","year":"2020","unstructured":"Ullrich S, Nitsche C (2020) The SARS-CoV-2 main protease as drug target. Bioorg Med Chem Lett 30:127377","journal-title":"Bioorg Med Chem Lett"},{"key":"941_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1021\/acs.accounts.2c00735","volume":"56","author":"B Tan","year":"2022","unstructured":"Tan B, Joyce R, Tan H, Hu Y, Wang J (2022) SARS-CoV-2 main protease drug design, assay development, and drug resistance studies. Acc Chem Res 56:157\u2013168","journal-title":"Acc Chem Res"},{"key":"941_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115491","volume":"257","author":"X Pang","year":"2023","unstructured":"Pang X, Xu W, Liu Y, Li H, Chen L (2023) The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022. Eur J Med Chem 257:115491","journal-title":"Eur J Med Chem"},{"key":"941_CR17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/biom14070797","volume":"14","author":"A Zag\u00f3rska","year":"2024","unstructured":"Zag\u00f3rska A, Czopek A, Fryc M, Jo\u0144czyk J (2024) Inhibitors of SARS-CoV-2 main protease (Mpro) as anti-coronavirus agents. Biomolecules 14:797","journal-title":"Biomolecules"},{"key":"941_CR18","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1021\/acsomega.2c07259","volume":"8","author":"CQ Duong","year":"2023","unstructured":"Duong CQ, Nguyen PTV (2023) Exploration of SARS-CoV-2 Mpro noncovalent natural inhibitors using structure-based approaches. ACS Omega 8:6679\u20136688","journal-title":"ACS Omega"},{"key":"941_CR19","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1038\/s41598-022-06306-4","volume":"12","author":"GG Rossetti","year":"2022","unstructured":"Rossetti GG, Ossorio MA, Rempel S, Kratzel A, Dionellis VS, Barriot S, Tropia L, Gorgulla C, Arthanari H, Thiel V, Mohr P, Gamboni R, Halazonetis TD (2022) Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits. Sci Rep 12:2505","journal-title":"Sci Rep"},{"issue":"4","key":"941_CR20","doi-asserted-by":"publisher","first-page":"174751982311847","DOI":"10.1177\/17475198231184799","volume":"47","author":"Z She","year":"2023","unstructured":"She Z, Yao Y, Wang C, Li Y, Xiong X, Liu Y (2023) Mpro-targeted anti-SARS-CoV-2 inhibitor-based drugs. J Chem Res 47(4):17475198231184800","journal-title":"J Chem Res"},{"key":"941_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.apsb.2023.08.004","volume":"14","author":"L Song","year":"2023","unstructured":"Song L, Gao S, Ye B, Yang M, Cheng Y, Kang D, Yi F, Sun J, Men\u00e9ndez-Arias L, Neyts J, Liu X, Zhan P (2023) Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors. Acta Pharm Sin B 14:87\u2013109","journal-title":"Acta Pharm Sin B"},{"key":"941_CR22","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.csbj.2022.03.009","volume":"20","author":"I Antonopoulou","year":"2022","unstructured":"Antonopoulou I, Sapountzaki E, Rova U, Christakopoulos P (2022) Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing\/designing drug-like substances and utilizing nature\u2019s toolbox of bioactive compounds. Comp Struct Biotechnol 20:1306\u20131344","journal-title":"Comp Struct Biotechnol"},{"key":"941_CR23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1021\/jm301580n","volume":"56","author":"J Jacobs","year":"2012","unstructured":"Jacobs J, Grum-Tokars V, Zhou Y, Turlington M, Saldanha SA, Chase P, Eggler A, Dawson ES, Baez-Santos YM, Tomar S, Mielech AM, Baker SC, Lindsley CW, Hodder P, Mesecar A, Stauffer SR (2012) Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(n-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (Sars-Cov) 3CL protease. J Med Chem 56:534\u2013546","journal-title":"J Med Chem"},{"key":"941_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/v13020174","volume":"1","author":"GJ Lockbaum","year":"2021","unstructured":"Lockbaum GJ, Reyes AC, Lee JM, Tilvawala R, Nalivaika EA, Ali A, Yilmaz NK, Thompson PR, Schiffer CA (2021) Crystal structure of SARS-CoV-2 main protease in complex with the non-covalent inhibitor ml188. Viruses 1:174","journal-title":"Viruses"},{"key":"941_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133706","volume":"276","author":"H Jiang","year":"2024","unstructured":"Jiang H, Li W, Zhou X, Zhang J, Li J (2024) Crystal structures of coronaviral main proteases in complex with the non-covalent inhibitor X77. Int J Biol Macromol 276:133706","journal-title":"Int J Biol Macromol"},{"key":"941_CR26","unstructured":"Structure of COVID-19 main protease bound to potent broad-spectrum non-covalent inhibitor X77. https:\/\/www.rcsb.org\/structure\/6W63"},{"key":"941_CR27","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1021\/jacs.1c08402","volume":"144","author":"A Luttens","year":"2022","unstructured":"Luttens A, Gullberg H, Abdurakhmanov E, Vo DD, Akaberi D, Talibov VO, Nekhotiaeva N, Vangeel L, De Jonghe S, Jochmans D, Krambrich J, Tas A, Lundgren B, Gravenfors Y, Craig AJ, Atilaw Y, Sandstr\u00f6m A, Moodie LWK, Lundkvist A, Carlsson J (2022) Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses. J Am Chem Soc 144:2905\u20132920","journal-title":"J Am Chem Soc"},{"key":"941_CR28","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1021\/acs.jmedchem.2c00117","volume":"65","author":"Y Unoh","year":"2022","unstructured":"Unoh Y, Uehara S, Nakahara K, Nobori H, Yamatsu Y, Yamamoto S, Maruyama Y, Taoda Y, Kasamatsu K, Suto T, Kouki K, Nakahashi A, Kawashima S, Sanaki T, Toba S, Uemura K, Mizutare T, Ando S, Sasaki M, Tachibana Y (2022) Discovery of S-217622, a noncovalent oral SARS-COV-2 3CL protease inhibitor clinical candidate for treating COVID-19. J Med Chem 65:6499\u20136512","journal-title":"J Med Chem"},{"key":"941_CR29","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40265-024-02039-y","volume":"84","author":"YY Syed","year":"2024","unstructured":"Syed YY (2024) Ensitrelvir fumaric acid: first approval. Drugs 84:721\u2013728","journal-title":"Drugs"},{"key":"941_CR30","unstructured":"Shionogi announces Xocova\u00ae (Ensitrelvir fumaric acid) obtained standard approval in Japan for the treatment of SARS-COV-2 infection. Published March 20, 2024. https:\/\/www.shionogi.com\/global\/en\/news\/2024\/03\/20240305.html"},{"key":"941_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/biom14010072","volume":"14","author":"Z Li","year":"2024","unstructured":"Li Z, Huang R, Xia M, Patterson TA, Hong H (2024) Fingerprinting interactions between proteins and ligands for facilitating machine learning in drug discovery. Biomolecules 14:72","journal-title":"Biomolecules"},{"key":"941_CR32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/cmdc.201700505","volume":"13","author":"F Da Silva","year":"2017","unstructured":"Da Silva F, Desaphy J, Rognan D (2017) IChem: a versatile toolkit for detecting, comparing, and predicting protein\u2013ligand interactions. ChemMedChem 13:507\u2013510","journal-title":"ChemMedChem"},{"key":"941_CR33","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1021\/acs.jproteome.0c00623","volume":"19","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Bourne PE (2020) Structural insights into the binding modes of viral RNA-dependent RNA polymerases using a function-site interaction fingerprint method for RNA virus drug discovery. J Proteome Res 19:4698\u20134705","journal-title":"J Proteome Res"},{"key":"941_CR34","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1080\/07391102.2020.1768151","volume":"39","author":"L Mittal","year":"2020","unstructured":"Mittal L, Kumari A, Srivastava M, Singh M, Asthana S (2020) Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach. J Biomol Struct Dyn 39:3662\u20133680","journal-title":"J Biomol Struct Dyn"},{"key":"941_CR35","first-page":"229","volume":"45","author":"N Burusliam","year":"2020","unstructured":"Burusliam N (2020) Prevention of virus using Thai traditional herbal medication. Chonburi Hosp J 45:229\u2013240","journal-title":"Chonburi Hosp J"},{"key":"941_CR36","first-page":"327","volume":"21","author":"S Radapong","year":"2023","unstructured":"Radapong S, Harnkit N, Sahad T, Suppajariyawat P, Okada PK, Sincharoenpokai P, Limprasert K, Niumsakul S, Banyati P, Ritchie KJ, Chaisomboonpan S (2023) Anti-SARS-CoV-2 activity and inhibition of ACE2 and TMPRSS2 expression of Ya Prasa Pro Yai, Ya Ha Rak and Ya Chanthalila traditional drug formulas. J Thai Trad Alt Med 21:327\u2013341","journal-title":"J Thai Trad Alt Med"},{"key":"941_CR37","first-page":"106","volume":"9","author":"K Sitthipatsarin","year":"2023","unstructured":"Sitthipatsarin K, Utsawapontanapat S, Rerksngarm T, Charoenying T (2023) Clinical outcomes of a treatment for mild cases of COVID-19 using a polyherbal concoction based on Thai traditional medicine: a retrospective chart review. J Thai Trad Alt Med 9:106\u2013121","journal-title":"J Thai Trad Alt Med"},{"key":"941_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-021-01651-8","volume":"18","author":"C Nie","year":"2021","unstructured":"Nie C, Trimpert J, Moon S, Haag R, Gilmore K, Kaufer BB, Seeberger PH (2021) In vitro efficacy of Artemisia extracts against SARS-CoV-2. Virol J 18:182","journal-title":"Virol J"},{"key":"941_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115682","volume":"168","author":"M Baggieri","year":"2023","unstructured":"Baggieri M, Gioacchini S, Borgonovo G, Catinella G, Marchi A, Picone P, Vasto S, Fioravanti R, Bucci P, Kojouri M, Giuseppetti R, Ugo E, Ubaldi F, Dallavalle S, Nuzzo D, Pinto A, Magurano F (2023) Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2. Biomed Pharmacother 168:115682","journal-title":"Biomed Pharmacother"},{"key":"941_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/plants11151914","volume":"11","author":"HM Abdallah","year":"2022","unstructured":"Abdallah HM, El-Halawany AM, Darwish KM, Algandaby MM, Mohamed GA, Ibrahim SRM, Koshak AE, Elhady SS, Fadil SA, Alqarni AA, Abdel-Naim AB, Elfaky MA (2022) Bio-guided isolation of SARS-CoV-2 main protease inhibitors from medicinal plants: in vitro assay and molecular dynamics. Plants 11:1914","journal-title":"Plants"},{"key":"941_CR41","doi-asserted-by":"publisher","first-page":"468","DOI":"10.53730\/ijhs.v6nS1.4779","volume":"6","author":"AF Dibha","year":"2022","unstructured":"Dibha AF, Wahyuningsih S, Kharisma VD, Ansori ANM, Widyananda MH, Parikesit AA, Rebezov M, Matrosova Y, Artyukhova S, Kenijz N, Kiseleva M, Jakhmola V, Zainul R (2022) Biological activity of kencur (Kaempferia galanga L.) against SARS-CoV-2 main protease. Int J Health Sci 6:468\u2013480","journal-title":"Int J Health Sci"},{"key":"941_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/ddc4020027","volume":"4","author":"BA Gomes","year":"2025","unstructured":"Gomes BA, Fernandes DA, Da Fonseca TS, Campos MF, Jural PA, Silva MVTE, Constant LEC, Da Veiga A, Ferreira BR, Magalh\u00e3es ES, Pereira HBM, De Mattos M, Oliveira B, Silva S, Amaral D, Oliveira DR, Leal R, Martins GR, Leit\u00e3o GG, Leit\u00e3o SG (2025) Plants metabolites as in vitro inhibitors of SARS-COV-2 targets: a systematic review and computational analysis. Drugs Candidates 4:27","journal-title":"Drugs Candidates"},{"key":"941_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1051\/wujns\/2022274349","volume":"27","author":"J Lei","year":"2022","unstructured":"Lei J, Tu Y, Xu J, Yu J (2022) Mechanisms of the traditional Chinese herb Atractylodes lancea against COVID-19 based on network pharmacology and molecular docking. Wuhan Univ J Nat Sci 27:349\u2013360","journal-title":"Wuhan Univ J Nat Sci"},{"key":"941_CR44","first-page":"1934578X2110166","volume":"16","author":"XY Lim","year":"2021","unstructured":"Lim XY, Chan JSW, Tan TYC, Teh BP, Razak MRMA, Mohamad S, Mohamed AFS (2021) Andrographis paniculata (Burm. F.) Wall. Ex Nees, andrographolide, and andrographolide analogues as SARS-CoV-2 antivirals? A rapid review. Nat Prod Comm 16:1934578X211016610","journal-title":"Nat Prod Comm"},{"key":"941_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77003-3","volume":"10","author":"P Kanjanasirirat","year":"2020","unstructured":"Kanjanasirirat P, Suksatu A, Manopwisedjaroen S, Munyoo B, Tuchinda P, Jearawuttanakul K, Seemakhan S, Charoensutthivarakul S, Wongtrakoongate P, Rangkasenee N, Pitiporn S, Waranuch N, Chabang N, Khemawoot P, Sa-Ngiamsuntorn K, Pewkliang Y, Thongsri P, Chutipongtanate S, Hongeng S, Thitithanyanont A (2020) High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents. Sci Rep 10:19963","journal-title":"Sci Rep"},{"key":"941_CR46","unstructured":"RCSB PDB: Homepage. https:\/\/www.rcsb.org\/"},{"key":"941_CR47","doi-asserted-by":"publisher","first-page":"7946","DOI":"10.1021\/acs.jmedchem.2c00487","volume":"65","author":"M Volkov","year":"2022","unstructured":"Volkov M, Turk AJ, Drizard N, Martin N, Hoffmann B, Gaston-Math\u00e9 Y, Rognan D (2022) On the frustration to predict binding affinities from protein-ligand structures with deep neural networks. J Med Chem 65:7946\u20137958","journal-title":"J Med Chem"},{"key":"941_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1021\/acs.jcim.8b00684","volume":"59","author":"VK Tran-Nguyen","year":"2018","unstructured":"Tran-Nguyen VK, Da Silva F, Bret G, Rognan D (2018) All in one: cavity detection, druggability estimate, cavity-based pharmacophore perception, and virtual screening. J Chem Inf Model 59:573\u2013585","journal-title":"J Chem Inf Model"},{"key":"941_CR49","unstructured":"SYBYL-X 2.1 Certara USA, Inc., 103 Carnegie Center, Suite 300, Princeton, NJ 08540 USA"},{"key":"941_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1021\/ci600342e","volume":"47","author":"G Marcou","year":"2007","unstructured":"Marcou G, Rognan D (2007) Optimizing fragment and scaffold docking by use of molecular interaction fingerprints. J Chem Inf Model 47:195\u2013207","journal-title":"J Chem Inf Model"},{"key":"941_CR51","unstructured":"OpeneEye Candence Molecular Science, https:\/\/www.eyesopen.com\/filter"},{"key":"941_CR52","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727\u2013748","journal-title":"J Mol Biol"},{"key":"941_CR53","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1021\/ci800298z","volume":"49","author":"O Korb","year":"2009","unstructured":"Korb O, St\u00fctzle T, Exner TE (2009) Empirical scoring functions for advanced protein-ligand docking with PLANTS. J Chem Inf Model 49:84\u201396","journal-title":"J Chem Inf Model"},{"key":"941_CR54","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1021\/acscentsci.3c01521","volume":"10","author":"F Sindt","year":"2024","unstructured":"Sindt F, Seyller A, Eguida M, Rognan D (2024) Protein structure-based organic chemistry-driven ligand design from ultralarge chemical spaces. ACS Cent Sci 10:615\u2013627","journal-title":"ACS Cent Sci"},{"key":"941_CR55","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1021\/acs.jcim.5c00730","volume":"65","author":"F Sindt","year":"2025","unstructured":"Sindt F, Bret G, Rognan D (2025) On the difficulty to rescore hits from ultralarge docking screens. J Chem Inf Model 65:5553\u20135566","journal-title":"J Chem Inf Model"},{"key":"941_CR56","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1021\/acs.jcim.2c00043","volume":"62","author":"P Penner","year":"2022","unstructured":"Penner P, Guba W, Schmidt R, Meyder A, Stahl M, Rarey M (2022) The Torsion Library: semiautomated improvement of torsion rules with SMARTScompare. J Chem Inf Model 62:1644\u20131653","journal-title":"J Chem Inf Model"},{"key":"941_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10822-012-9626-2","volume":"27","author":"N Schneider","year":"2013","unstructured":"Schneider N, Lange G, Hindle S, Klein R, Rarey M (2013) A consistent description of hydrogen bond and dehydration energies in protein-ligand complexes: methods behind the hyde scoring function. J Comput-Aided Mol Des 27:15\u201329","journal-title":"J Comput-Aided Mol Des"},{"key":"941_CR58","doi-asserted-by":"publisher","first-page":"9418","DOI":"10.1021\/acs.jpcb.4c04901","volume":"128","author":"JA Lemkul","year":"2024","unstructured":"Lemkul JA (2024) Introductory tutorials for simulating protein dynamics with GROMACS. J Phys Chem B 128:9418\u20139435","journal-title":"J Phys Chem B"},{"key":"941_CR59","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H, Li X, Caricato M, Marenich A, Bloino J, Janesko BG, Gomperts R, Mennucci B, Hratchian HP, Ortiz JV, Izmaylov AF, Sonnenberg JL, Williams-Young D, Ding F, Lipparini F, Egidi F, Goings J, Peng B, Petrone A, Henderson T, Ranasinghe D, Zakrzewski VG, Gao J, Rega N, Zheng G, Liang W, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Throssell K, Montgomery Jr JA, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Keith T, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Millam JM, Klene M, Adamo C, Cammi R, Ochterski JW, Martin RL, Morokuma K, Farkas O, Foresman JB, Fox DJ (2016) Gaussian 09, Revision A.02. Gaussian, Inc., Wallingford CT"},{"key":"941_CR60","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/bioinformatics\/btad350","volume":"39","author":"L Kagami","year":"2023","unstructured":"Kagami L, Wilter A, Diaz A, Vranken W (2023) The ACPYPE web server for small-molecule MD topology generation. Bioinformatics 39:350","journal-title":"Bioinformatics"},{"key":"941_CR61","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi G, Donadio D, Parrinello M (2007) Canonical sampling through velocity rescaling. J Chem Phys 126:014101","journal-title":"J Chem Phys"},{"key":"941_CR62","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182\u20137190","journal-title":"J Appl Phys"},{"key":"941_CR63","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/(SICI)1521-3773(19990115)38:1\/2<236::AID-ANIE236>3.0.CO;2-M","volume":"38","author":"X Daura","year":"1999","unstructured":"Daura X, Gademann K, Jaun B, Seebach D, van Gunsteren WF, Mark AE (1999) Peptide folding: when simulation meets experiment. Angew Chem Int Ed 38:236\u2013240","journal-title":"Angew Chem Int Ed"},{"key":"941_CR64","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E (2021) gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput 17:6281\u20136291","journal-title":"J Chem Theory Comput"},{"key":"941_CR65","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H, Roitberg A (2012) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8:3314\u20133321","journal-title":"J Chem Theory Comput"},{"key":"941_CR66","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.abb4489","volume":"368","author":"W Dai","year":"2020","unstructured":"Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu H (2020) Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 368:1331\u20131335","journal-title":"Science"},{"key":"941_CR67","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1126\/science.abg5827","volume":"373","author":"N Drayman","year":"2021","unstructured":"Drayman N, DeMarco JK, Jones KA, Azizi S, Froggatt HM, Tan K, Maltseva NI, Chen S, Nicolaescu V, Dvorkin S, Furlong K, Kathayat RS, Firpo MR, Mastrodomenico V, Bruce EA, Schmidt MM, Jedrzejczak R, Mu\u00f1oz-Al\u00eda M\u00c1, Schuster B, Tay S (2021) Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. Science 373:931\u2013936","journal-title":"Science"},{"issue":"1","key":"941_CR68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.apsb.2023.08.004","volume":"14","author":"L Song","year":"2024","unstructured":"Song L, Gao S, Ye B, Yang M, Cheng Y, Kang D, Yi F, Sun JP, Men\u00e9ndez-Arias L, Neyts J, Liu X, Zhan P (2024) Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors. Acta Pharm Sin B 14(1):87\u2013109","journal-title":"Acta Pharm Sin B"},{"key":"941_CR69","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1126\/science.abf7945","volume":"372","author":"S G\u00fcnther","year":"2021","unstructured":"G\u00fcnther S, Reinke PYA, Fern\u00e1ndez-Garc\u00eda Y, Lieske J, Lane TJ, Ginn HM, Koua FHM, Ehrt C, Ewert W, Oberthuer D, Yefanov O, Meier S, Lorenzen K, Krichel B, Kopicki J, Gelisio L, Brehm W, Dunkel I, Hinrichs W (2021) X-ray screening identifies binding subsites and allosteric inhibitors of SARS-CoV-2 main protease. Science 372:642\u2013646","journal-title":"Science"},{"key":"941_CR70","doi-asserted-by":"publisher","first-page":"9732","DOI":"10.1021\/acs.jmedchem.9b01184","volume":"62","author":"F Da Silva","year":"2019","unstructured":"Da Silva F, Bret G, Teixeira L, Gonzalez CF, Rognan D (2019) Exhaustive repertoire of druggable cavities at protein\u2212protein interfaces of known three-dimensional structure. J Med Chem 62:9732\u20139742","journal-title":"J Med Chem"},{"key":"941_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1023\/A:1016357811882","volume":"16","author":"R Wang","year":"2002","unstructured":"Wang R, Lai L, Wang S (2002) Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J Comput-Aided Mol Des 16:11\u201326","journal-title":"J Comput-Aided Mol Des"},{"key":"941_CR72","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevLett.91.018102","volume":"9","author":"A Fern\u00e1ndez","year":"2003","unstructured":"Fern\u00e1ndez A, Scott RA (2003) Dehydration of hot-cold interfaces and the formulation of interactions in protein folding and recognition. Phys Rev Lett 9:018102","journal-title":"Phys Rev Lett"},{"key":"941_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008061","volume":"17","author":"B Coventry","year":"2021","unstructured":"Coventry B, Baker D (2021) Protein sequence optimization with a pairwise decomposable penalty for buried unsatisfied hydrogen bonds. PLoS Comput Biol 17:e1008061","journal-title":"PLoS Comput Biol"},{"key":"941_CR74","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1021\/acs.jnatprod.2c00736","volume":"85","author":"R Choonong","year":"2022","unstructured":"Choonong R, Ruangdachsuwan S, Churod T, Palabodeewat S, Punyahathaikul S, Juntarapornchai S, Ketsuwan K, Komaikul J, Masrinoul P, Kitisripanya T, Juengwatanatrakul T, Yusakul G, Kanchanapoom T, Putalun W (2022) Evaluating the in vitro efficacy of quassinoids from Eurycoma longifolia and Eurycoma harmandiana against common cold human coronavirus OC43 and SARS-CoV-2 using in-cell enzyme-linked immunosorbent assay. J Nat Prod 85:2779\u20132788","journal-title":"J Nat Prod"},{"key":"941_CR75","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0944-7113(99)80046-4","volume":"6","author":"F Benencia","year":"1999","unstructured":"Benencia F, Courr\u00e8ges MC (1999) Antiviral activity of sandalwood oil against herpes simplex viruses-1 and -2. Phytomedicine 6:119\u2013123","journal-title":"Phytomedicine"},{"key":"941_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.661331","volume":"8","author":"M Ghidoli","year":"2021","unstructured":"Ghidoli M, Colombo F, Sangiorgio S, Landoni M, Giupponi L, Nielsen E, Pilu R (2021) Food containing bioactive flavonoids and other phenolic or sulfur phytochemicals with antiviral effect: can we design a promising diet against COVID-19? Front Nutr 8:661331","journal-title":"Front Nutr"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00941-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00941-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00941-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:05:22Z","timestamp":1789722322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00941-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["941"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00941-z","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"234"}}